Gastrointestinal Cancer

Top Story

FDA approves Ontruzant, biosimilar to Herceptin, for breast and gastric cancers

January 18, 2019
Meeting News

Adjuvant durvalumab safe, active for locally advanced esophageal adenocarcinoma

January 17, 2019
Adjuvant durvalumab administered after trimodality therapy appeared safe for patients with locally advanced esophageal and gastroesophageal junction adenocarcinoma…
In the Journals

Undiagnosed HBV, HCV, HIV prevalent in newly diagnosed cancer cases

January 17, 2019
Researchers discovered a substantial proportion of patients with newly diagnosed cancer and concurrent hepatitis C or hepatitis B were unaware of their viral infection…
Feature

Corticosteroids, IV antibiotics increase risk for chemotherapy-induced febrile neutropenia

January 17, 2019
Use of corticosteroids, certain dermatologic or mucosal conditions, and antibiotics all appeared to increase risk for chemotherapy-induced febrile neutropenia among a…
More Headlines »
CME

Improving Colorectal Cancer Prevention: Latest Advances to Improve Adenoma Detection Rates

This activity is supported by an educational grant from Aries Pharmaceuticals Inc.

Colorectal cancer (CRC) is the third most common type of cancer worldwide and second deadliest form of cancer in the…
More »
Video
Meeting News

ASGE launches heartburn awareness campaign to preempt esophageal cancer

June 26, 2018
More »
Resource Centers
At Issue: Colorectal Cancer Resource Center

At Issue: Colorectal Cancer Resource Center

CME

Checkpoint Inhibitors in Gastrointestinal Tumors: The Latest Evidence on Safety, Efficacy, and Biomarkers

This educational activity is supported by an independent medical educational grant from Merck & Co., Inc.

The genomes of cancers deficient in mismatch repair (MMR) contain extremely high numbers of somatic mutations. Analysis…
More »